JYNTHIGH SIGNALFINANCIAL10-K

JYNT experienced a dramatic financial deterioration with net income swinging from $1.2M profit to a $9.8M loss while simultaneously conducting $11.3M in share buybacks despite negative profitability.

The company's decision to spend $11.3M on share buybacks while posting significant losses raises serious questions about capital allocation and financial management. The massive 322% increase in SG&A expenses coupled with declining operating performance suggests potential operational challenges or one-time charges that warrant immediate investor scrutiny.

Comparing 2026-03-13 vs 2025-03-14View on EDGAR →
FINANCIAL ANALYSIS

JYNT's financial picture deteriorated significantly with net income plummeting from $1.2M to negative $9.8M and operating cash flow declining 80.5% to just $1.8M. The company dramatically increased share buybacks from $10K to $11.3M while SG&A expenses exploded 322% to $44.6M, indicating either major operational inefficiencies or significant one-time costs. Despite the poor performance, the balance sheet showed some improvement with debt reduction and lower current liabilities, though current assets also declined substantially, creating a mixed but concerning overall financial picture.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+117958.9%
$10K$11.3M

Share repurchases increased 117958.9% — management returning capital, signals confidence in intrinsic value.

Net Income
P&L
-928.4%
$1.2M-$9.8M

Net income declined 928.4% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-667.6%
$161K-$913K

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

SG&A Expense
P&L
+322.2%
$10.6M$44.6M

SG&A up 322.2% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Operating Cash Flow
Cash Flow
-80.5%
$9.4M$1.8M

Operating cash flow fell 80.5% — earnings quality concerns; investigate working capital changes and non-cash items.

Total Debt
Balance Sheet
-69.8%
$332K$100K

Debt reduced 69.8% — deleveraging strengthens balance sheet and reduces financial risk.

Current Liabilities
Balance Sheet
-33.5%
$49.4M$32.8M

Current liabilities reduced — improved short-term financial position and working capital health.

Current Assets
Balance Sheet
-27.8%
$72.2M$52.1M

Current assets declined 27.8% — monitor working capital adequacy and short-term liquidity.

Capital Expenditure
Cash Flow
+26.8%
$1.2M$1.5M

Capex increased 26.8% — ongoing investment in capacity or infrastructure for future growth.

Total Liabilities
Balance Sheet
-26.6%
$62.5M$45.9M

Liabilities reduced 26.6% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-03-13
PRIOR — 2025-03-14
ADDED
There were 14,114,334 shares of the registrant s common stock outstanding as of March 9, 2026.
We delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million of system-wide sales, respectively, across our highly franchised network.
We will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad.
Since acquiring the predecessor to our company in March 2010, we have grown our enterprise from eight to 960 clinics in operation as of December 31, 2025, with an additional 82 franchise licenses sold but not yet developed across our network, and 57 letters of intent for 57 future clinic licenses.
As of December 31, 2025, our franchisees owned or managed 885 clinics, and we owned or managed 75 clinics.
+7 more — sign up free →
REMOVED
There were 15,174,931 shares of the registrant s common stock outstanding as of March 10, 2025.
We delivered over 14.7 million patient visits in 2024, up from 13.6 million patient visits in 2023, generating over $530.3 million and $488 million of system-wide sales, respectively, across our highly franchised network.
We will continue the rapid and franchise focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad.
Since acquiring the predecessor to our company in March 2010, we have grown our enterprise from eight to 967 clinics in operation as of December 31, 2024, with an additional 92 franchise licenses sold but not yet developed across our network, and 53 letters of intent for 53 future clinic licenses.
As of December 31, 2024, our franchisees owned or managed 842 clinics, and we owned or managed 125 clinics.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →